Cell Counting Market Trends

Growth Drivers

• Growing Prevalence of Infectious Diseases – On account of the increasing population density, the market is expected to expand more in the upcoming years. As of 2018, more than 30% of people in India had infectious illnesses.

• Rising Geriatric Population – Elderly population is more prone to chronic illness, which is estimated to drive market growth. The percentage of individuals over 60 in the world will nearly double from 12 to 22% between 2015 and 2050.

• Rising Number of Blood-Related Problems – Specific nutrient deficiency resulting from poor diet, and unhealthy lifestyle among people, is estimated to drive the market growth.  Further, blood problems are caused by a variety of factors, such as genes, side effects of certain drugs, and other illnesses. In Australia, blood cancer and other associated blood illnesses are predicted to claim the lives of over 5,000 persons in 2022.

• Increasing Health Spending – According to the most recent expenditure data, health spending in the US rose by over 9% in 2019.

• Surging Incidences Target Diseases such as HIV – HIV (human immunodeficiency virus) targets immune system cells. After being diagnosed with HIV, the CD4+ cell count is routinely assessed. An immunosuppressed state from HIV is indicated by a low CD4 level, which is anticipated to drive market growth. It was discovered that there were over 38 million HIV-positive individuals worldwide in 2021.

Challenges

• Exorbitant Cost of Cell Analysis - The high cost of automated cell counting technologies, is one of the major factors predicted to slow down the market growth. For instance, many are unable to afford cell counting techniques for medical or research purposes owing to the high prices of the apparatus, equipment, and procedures.

• Lack of Knowledgeable Medical Professionals

• Absence of Knowledge